{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:10:19Z","timestamp":1790770219658,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Lavender essential oil and tea tree essential oil have become popular ingredients in personal care and household products in recent decades. Questions regarding the safety of these oils in pediatric populations have been raised, proposing a link between these essential oils and endocrine disruption in children, specifically prepubertal gynecomastia. To date, no epidemiological studies have been conducted to evaluate this proposed link.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This is a cross sectional study conducted among parents of children in the United States to identify the prevalence of endocrine disruption in children aged 2\u201415 years old. This study also evaluates the potential for a relationship between the exposure of lavender essential oil and tea tree essential oil products and endocrine disrupting outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In 556 children with a mean age of 6.33 (SD = 3.92), prevalence of endocrine disruption was .016 (SD = 0.13). No cases of prepubertal gynecomastia were identified in either group, and prevalence of precocious puberty, delayed puberty, growth hormone deficiency, and hypothyroidism were all consis-tent with population norms. Total risk of endocrine disorders among those exposed (0.0194) did not differ from the risk of those unexposed (0.0069). The risk ratio was 2.796 (95% CI: 0.352,22.163,\n                      <jats:italic toggle=\"yes\">P =<\/jats:italic>\n                      .458).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Children who were regularly exposed to lavender or tea tree essential oils experienced the same risk of endocrine disorders as those who were not exposed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijpam.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T13:05:39Z","timestamp":1634043939000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence of endocrine disorders among children exposed to Lavender Essential Oil and Tea Tree Essential Oils"],"prefix":"10.4103","volume":"9","author":[{"given":"Jessie","family":"Hawkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Hires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20240903","first-page":"344","article-title":"Lavender","volume":"22","author":"Wu","year":"2011","journal-title":"Dermatitis"},{"key":"R2-9-20240903","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/CMR.19.1.50-62.2006","article-title":"Melaleuca alternifolia (Tea Tree) oil: a re-view of antimicrobial and other medicinal properties","volume":"19","author":"Carson","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"R3-9-20240903","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOP.0b013e32835e1eb6","article-title":"Phthalate exposure and children's health","volume":"25","author":"Braun","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"R4-9-20240903","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2334-6-158","article-title":"In vivo ac-tivity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species","volume":"6","author":"Mondello","year":"2006","journal-title":"BMC Infect Dis"},{"key":"R5-9-20240903","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ptr.1103","article-title":"Biological activities of lavender essential oil","volume":"16","author":"Cavanagh","year":"2002","journal-title":"Phytother Res"},{"key":"R6-9-20240903","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJMoa064725","article-title":"Prepubertal gynecomastia linked to lavender and tea tree oils","volume":"356","author":"Henley","year":"2007","journal-title":"N Engl J Med"},{"key":"R7-9-20240903","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00431-020-03799-x","article-title":"Prepubertal gynecomastia is not always idiopathic: case series and review of the literature","volume":"180","author":"Laimon","year":"2021","journal-title":"Eur J Pediatr"},{"key":"R8-9-20240903","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/eem.11.57","article-title":"Gynecomastia: incidence, causes and treatment","volume":"6","author":"Deepinder","year":"2011","journal-title":"Expert Rev Endocrinol Metab"},{"key":"R9-9-20240903","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jadohealth.2007.03.010","article-title":"Relationship of adolescent gynecomastia with varicocele and somatometric parameters: a cross-sectional study in 6200 healthy boys","volume":"41","author":"Kumanov","year":"2007","journal-title":"J Adolesc Health"},{"key":"R10-9-20240903","doi-asserted-by":"crossref","first-page":"102288","DOI":"10.1016\/j.ctim.2019.102288","article-title":"The relationship between lavender and tea tree essential oils and pediatric endocrine disorders: a systematic review of the literature","volume":"49","author":"Hawkins","year":"2020","journal-title":"Compl Ther Med"},{"key":"R11-9-20240903","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1210\/jc.2018-01880","article-title":"Lavender products associated with premature thelarche and prepubertal gynecomastia: case reports and endocrine-disrupting chemical activities","volume":"104","author":"Ramsey","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-9-20240903","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1515\/jpem-2015-0248","article-title":"Prepubertal gynecomastia and chronic lavender exposure: report of three cases","volume":"29","author":"Diaz","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R13-9-20240903","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.crvi.2017.07.004","article-title":"What is an endocrine disruptor?","volume":"340","author":"Monneret","year":"2017","journal-title":"C R Biol"},{"key":"R14-9-20240903","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1001\/archpediatrics.2012.241","article-title":"Exposure to environmental endocrine disruptors and child development","volume":"166","author":"Meeker","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R16-9-20240903","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/jes.2014.32","article-title":"Estrogenic and anti-estrogenic activity of off-the-shelf hair and skin care products","volume":"25","author":"Myers","year":"2015","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"R17-9-20240903","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/jama.2011.322","article-title":"Statistical association and causation: contributions of different types of evidence","volume":"305","author":"Hennekens","year":"2011","journal-title":"J Am Med Assoc"},{"key":"R18-9-20240903","doi-asserted-by":"crossref","first-page":"e2677","DOI":"10.1210\/clinem\/dgaa226","article-title":"Letter to the editor: \"lavender products associated with premature thelarche and prepubertal gynecomastia: case reports and endocrine-disrupting chemical activities","volume":"105","author":"Giroux","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-9-20240903","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/jmf.2014.0040","article-title":"Protective Effect of Lavandula stoechas and Rosmarinus officinalis essential oils against reproductive dam-age and oxidative stress in alloxan-induced diabetic rats","volume":"18","author":"Sebai","year":"2015","journal-title":"J Med Food"},{"key":"R21-9-20240903","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1091581812472209","article-title":"Uterotrophic assay of percutaneous lavender oil in immature female rats","volume":"32","author":"Politano","year":"2013","journal-title":"Int J Toxicol"},{"key":"R22-9-20240903","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.psyneuen.2007.11.015","article-title":"Olfactory influences on mood and autonomic, endocrine, and immune function","volume":"33","author":"Kiecolt-Glaser","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"R23-9-20240903","doi-asserted-by":"crossref","first-page":"dgaa392","DOI":"10.1210\/clinem\/dgaa392","article-title":"Letter to the editor: \"lavender products associated with premature thelarche and 1 prepubertal gynecomastia: case reports and endocrine- disrupting chemical activities","volume":"105","author":"Larkman","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-9-20240903","doi-asserted-by":"crossref","first-page":"159","DOI":"10.6065\/apem.2014.19.3.159","article-title":"Prepubertal unilateral gynecomastia in the absence of endocrine abnormalities","volume":"19","author":"Kang","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"R25-9-20240903","doi-asserted-by":"crossref","first-page":"e17374","DOI":"10.1097\/MD.0000000000017374","article-title":"Idiopathic prepubertal unilateral gynecomastia: case report and literature review","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine (Baltim"},{"key":"R28-9-20240903","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/14656566.2018.1491966","article-title":"Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence- based treatment review","volume":"19","author":"Strawn","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"R29-9-20240903","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00431-020-03595-7","article-title":"Can lavender oil inhalation help to overcome dental anxiety and pain in children? A randomized clinical trial","volume":"179","author":"Arslan","year":"2020","journal-title":"Eur J Pediatr"},{"key":"R30-9-20240903","doi-asserted-by":"crossref","first-page":"101182","DOI":"10.1016\/j.ctcp.2020.101182","article-title":"The effects of lavender aromatherapy on stress and pain perception in children during dental treatment: a randomized clinical trial","volume":"40","author":"Ghaderi","year":"2020","journal-title":"Complement Ther Clin Pract"},{"key":"R31-9-20240903","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/j.pedn.2019.01.010","article-title":"The use of the Buzzy, Jet Lidokaine, Bubble-blowing and aromatherapy for reducing pediatric pain, stress and fear asso-ciated with phlebotomy","volume":"45","author":"K\u00fc\u00e7\u00fck","year":"2019","journal-title":"J Pediatr Nurs"},{"key":"R32-9-20240903","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s12906-016-1441-1","article-title":"Aromatherapy for the treatment of PONV in children: a pilot RCT","volume":"16","author":"Kiberd","year":"2016","journal-title":"BMC Compl Alternative Med"},{"key":"R33-9-20240903","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.ijporl.2013.07.014","article-title":"Evaluation of the effect of aromatherapy with lavender essential oil on post-tonsillectomy pain in pediatric patients: a randomized controlled trial","volume":"77","author":"Soltani","year":"2013","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R34-9-20240903","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-5945-10-6","article-title":"A randomised, assessor blind, parallel group compar-ative efficacy trial of three products for the treatment ofhead lice in children- melaleuca oil and lavender oil, pyrethrins and piperonyl butoxide, and a \"suffocation\" product","volume":"10","author":"Barker","year":"2010","journal-title":"BMC Dermatol"},{"key":"R35-9-20240903","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40368-019-00445-5","article-title":"The effect of aloe vera and tea tree oil mouthwashes on the oral health of school children","volume":"21","author":"Kamath","year":"2020","journal-title":"Eur Arch Paediatr Dent"},{"key":"R36-9-20240903","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1111\/ajd.12626","article-title":"The efficacy of Australian essential oils for the treat-ment of head lice infestation in children: a randomised controlled trial","volume":"59","author":"Greive","year":"2018","journal-title":"Australas J Dermatol"},{"key":"R37-9-20240903","first-page":"349","article-title":"Combination of essential oil of Melaleuca alternifolia and iodine in the treatment of molluscum contagiosum in children","volume":"11","author":"Markum","year":"2012","journal-title":"J Drugs Der-matol JDD"},{"key":"R38-9-20240903","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40268-014-0065-5","article-title":"No interacting in-fluence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol\/levonorgestrel combination","volume":"14","author":"Heger-Mahn","year":"2014","journal-title":"Drugs R"},{"key":"R39-9-20240903","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/1872214811666170301124033","article-title":"Gynecomastia in infants, children, and adolescents","volume":"10","author":"Leung","year":"2017","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"R40-9-20240903","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S2213-8587(15)00380-0","article-title":"Causes, diagnosis, and treatment of central precocious puberty","volume":"4","author":"Latronico","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R41-9-20240903","doi-asserted-by":"crossref","first-page":"101300","DOI":"10.1016\/j.beem.2019.101300","article-title":"Endocrine disrupters and possible contribution to pubertal changes","volume":"33","author":"Fudvoye","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"R42-9-20240903","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0025-6196(11)60671-X","article-title":"Gynecomastia: pathophysiology, evaluation, and management","volume":"84","author":"Johnson","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"R43-9-20240903","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MOP.0b013e328306a07c","article-title":"Gynecomastia in adolescents","volume":"20","author":"Nordt","year":"2008","journal-title":"Curr Opin Pediatr"},{"key":"R44-9-20240903","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/MOP.0b013e328305e415","article-title":"Gynecomastia in prepubertal and pubertal men","volume":"20","author":"Ma","year":"2008","journal-title":"Curr Opin Pediatr"},{"key":"R45-9-20240903","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.2004.02059.x","article-title":"Prepubertal gynaeco- mastia: aetiology, course and outcome","volume":"61","author":"Einav-Bachar","year":"2004","journal-title":"Clin Endocrinol (Oxf"},{"key":"R46-9-20240903","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ecam\/nen023","article-title":"Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use","volume":"7","author":"Bishop","year":"2010","journal-title":"Evid Based Complement Alternat Med"},{"key":"R47-9-20240903","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1552-6909.2007.00145.x","article-title":"Precocious puberty: a comprehensive review of literature","volume":"36","author":"Cesario","year":"2007","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"R48-9-20240903","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0009922814541807","article-title":"A pediatrician's guide to central precocious puberty","volume":"54","author":"Kletter","year":"2015","journal-title":"Clin Pediatr (Phila)"},{"key":"R50-9-20240903","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1542\/pir.22.9.309","article-title":"Delayed puberty","volume":"22","author":"Rosen","year":"2001","journal-title":"Pediatr Rev"},{"key":"R51-9-20240903","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/pir.31.5.189","article-title":"Delayed puberty","volume":"31","author":"Kaplowitz","year":"2010","journal-title":"Pediatr Rev"},{"key":"R52-9-20240903","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MED.0b013e32834ec952","article-title":"Diagnosis of growth hormone deficiency in childhood","volume":"19","author":"Stanley","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R53-9-20240903","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/adc.83.3.207","article-title":"Prevalence and aetiology of hypothyroidism in the young","volume":"83","author":"Hunter","year":"2000","journal-title":"Arch Dis Child"}],"container-title":["International Journal of Pediatrics and Adolescent Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352646721000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352646721000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.ijpam.2021.10.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:08:36Z","timestamp":1787166516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.ijpam.2021.10.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijpam.2021.10.001","relation":{},"ISSN":["2352-6467"],"issn-type":[{"value":"2352-6467","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}